Research has shown intermittent fasting to be a promising treatment for obesity, but it may trigger side effects like nausea or low blood sugar, so check with your doctor before trying it for yourself
The researchers found that among 334 patients receiving oral semaglutide at a 50 mg dose, three to nine patients experienced altered skin sensations including dysesthesias, hyperesthesia, neuralgia, pain of skin, paresthesia, sensitive skin, and skin burning sensation
For the first time ever, Medicare will cover GLP-1 medications specifically for weight loss, not just for diabetes or other conditions
theyre biological signals that the medication is actively engaging with your system
Zepbound shows superior weight loss compared to Wegovy in SURMOUNT-5 trial